HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiuwei Chen Selected Research

Shuangdan

1/2022Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiuwei Chen Research Topics

Disease

27Neoplasms (Cancer)
11/2023 - 12/2011
12Ovarian Neoplasms (Ovarian Cancer)
06/2023 - 01/2016
12Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 01/2011
7Endometrial Neoplasms (Endometrial Cancer)
11/2023 - 02/2013
5Lymphatic Metastasis
08/2021 - 07/2011
5Neoplasm Metastasis (Metastasis)
11/2017 - 07/2011
4Carcinoma (Carcinomatosis)
09/2018 - 01/2015
3Carcinogenesis
01/2023 - 02/2013
3Ovarian Epithelial Carcinoma
08/2021 - 07/2011
2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
09/2018 - 01/2017
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Hypoxia (Hypoxemia)
01/2019
1Tuberculosis (Tuberculoses)
08/2018
1Ascites
11/2017
1Adenocarcinoma
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2015
1Vascular Diseases (Vascular Disease)
10/2013

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
11/2023 - 07/2011
9Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2015
3Cisplatin (Platino)FDA LinkGeneric
11/2023 - 12/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 01/2022
3QuercetinIBA
02/2020 - 01/2019
2Long Noncoding RNAIBA
11/2023 - 08/2021
2Lysine (L-Lysine)FDA Link
11/2022 - 06/2021
2Messenger RNA (mRNA)IBA
11/2022 - 01/2017
2EnzymesIBA
09/2022 - 07/2022
2PolyethyleneimineIBA
01/2022 - 01/2022
2PlatinumIBA
01/2022 - 01/2022
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2022
2Metal-Organic FrameworksIBA
02/2020 - 01/2019
2Carbonic Anhydrase IXIBA
02/2020 - 01/2019
2Transcription Factors (Transcription Factor)IBA
09/2018 - 01/2017
21,1-dimethyl-4-acetylpiperaziniumIBA
09/2018 - 01/2017
2MicroRNAs (MicroRNA)IBA
01/2017 - 10/2013
2Carrier Proteins (Binding Protein)IBA
09/2015 - 01/2015
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
11/2023
1Arginine (L-Arginine)FDA Link
11/2023
1Therapeutic UsesIBA
11/2023
1Glutathione (Reduced Glutathione)IBA
06/2023
1SOXC Transcription FactorsIBA
01/2023
1Histone DemethylasesIBA
11/2022
14,6- dimorpholino- N- (4- nitrophenyl)- 1,3,5- triazin- 2- amineIBA
09/2022
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2022
1UbiquitinIBA
09/2022
1Sirolimus (Rapamycin)FDA Link
09/2022
1RNA (Ribonucleic Acid)IBA
07/2022
1Capsules (Microcapsules)IBA
01/2022
1AntibodiesIBA
01/2022
1Drug CombinationsIBA
01/2022
1Adenosine Triphosphatases (ATPase)IBA
01/2022
1Nonprescription Drugs (Patent Medicines)IBA
01/2022
1GoldIBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2022
1ShuangdanIBA
01/2022
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2022
1CD36 AntigensIBA
01/2022
1ArrestinIBA
01/2022
1Ubiquitin-Conjugating EnzymesIBA
01/2022
1Scavenger Receptors (Scavenger Receptor)IBA
01/2022
1Caspase 3 (Caspase-3)IBA
01/2022
1CarcinogensIBA
06/2021
1rat CLIC1 proteinIBA
06/2021
1pyrrolidine dithiocarbamic acidIBA
06/2021
1prolinedithiocarbamate (PDTC)IBA
06/2021
1Connective Tissue Growth FactorIBA
01/2019
1hyperosideIBA
01/2019
1AcidsIBA
01/2019
1Air Pollutants (Pollutants, Air)IBA
08/2018
1Prealbumin (Transthyretin)IBA
11/2017
1CA-125 Antigen (CA 125 Antigen)IBA
11/2017
1ATPases Associated with Diverse Cellular ActivitiesIBA
06/2015
1Glycoproteins (Glycoprotein)IBA
02/2013
1squamous cell carcinoma-related antigenIBA
01/2013
1Paclitaxel (Taxol)FDA LinkGeneric
02/2012
1nedaplatinIBA
02/2012
1Phosphotransferases (Kinase)IBA
12/2011
1rat MIRN31 microRNAIBA
12/2011

Therapy/Procedure

5Therapeutics
07/2022 - 01/2017
4Radiotherapy
11/2023 - 01/2013
4Drug Therapy (Chemotherapy)
01/2022 - 07/2011
3Neoadjuvant Therapy
08/2014 - 01/2011
2Lymph Node Excision (Lymph Node Dissection)
09/2014 - 01/2011
2Hysterectomy
09/2014 - 01/2011
1Immunotherapy
07/2022
1Chemoradiotherapy
01/2011